tm logo
COVIDSEQ
Live/Registered
REGISTERED

on 25 Oct 2022

Last Applicant/ Owned by

5200 Illumina Way

San Diego

CA

92122

Serial Number

88983895 filed on 24th Apr 2020

Registration Number

6885352 registered on 25th Oct 2022

in the Principal Register

Correspondent Address

Susan M. Natland

Susan M. Natland

2040 MAIN ST., 14TH FLOOR

IRVINE CA 92614

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

COVIDSEQ

Diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use; Diagnostic reagents and preparations for medical use; Kits comprised principally of diagnostic reagents with a protocol for use thereof for medical purposes; Kits comprised of diagnostic nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparation Read More

Classification Information


Class [001]
Chemical Products


Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19


First Use Date in General

14th May 2020

First Use Date in Commerce

09th Jun 2020

Class [005]
Pharmaceutical Products


Diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use; Diagnostic reagents and preparations for medical use; Kits comprised principally of diagnostic reagents with a protocol for use thereof for medical purposes; Kits comprised of diagnostic nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, biological preparations for medical genetic testing and medical diagnostic purposes; diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use in the fields of medical diagnostics, clinical diagnostics, medical forensics, laboratory medicine, genetic testing, and genetics; all of the foregoing for the detection of or in the field of COVID-19


First Use Date in General

14th May 2020

First Use Date in Commerce

09th Jun 2020

Mark Details


Serial Number

No 88983895

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ILLINCT.690T

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th Oct 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
25th Oct 2022REGISTERED-PRINCIPAL REGISTER
20th Sep 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
19th Sep 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
19th Sep 2022TEAS/EMAIL CORRESPONDENCE ENTERED
19th Sep 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
19th Sep 2022ASSIGNED TO LIE
07th Sep 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
20th Jul 2022TEAS EXTENSION RECEIVED
08th Mar 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED